Moleculin Biotech, Inc. (MBRX) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $2.47 (-0.80%)
Consensus Target
—
Upside
—
Analysts
1
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
MBRX vs Sector & Market
| Metric | MBRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | — | +1708.8% | +16.4% |
| P/E Ratio | -1.27 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $71M | $71M | $71M | 3 |
| 2027-12-31 | $42M | $42M | $42M | 2 |
| 2028-12-31 | $87M | $87M | $87M | 2 |
| 2029-12-31 | $52M | $52M | $52M | 1 |
| 2030-12-31 | $120M | $120M | $120M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-8.86 | $-6.91 | $-4.96 | 1 |
| 2027-12-31 | $-3.96 | $-3.96 | $-3.96 | 1 |
| 2028-12-31 | $-4.83 | $-3.56 | $-2.28 | 2 |
| 2029-12-31 | $0.96 | $0.96 | $0.96 | 1 |
| 2030-12-31 | $5.86 | $5.86 | $5.86 | 1 |
Frequently Asked Questions
What is the analyst consensus for MBRX?
The consensus among 1 analysts covering Moleculin Biotech, Inc. (MBRX) is Buy with an average price target of N/A.
How many analysts cover MBRX?
1 analysts have issued ratings for Moleculin Biotech, Inc. in the past 12 months.
Is MBRX a buy or sell right now?
Based on 1 analyst ratings, MBRX has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for MBRX?
Analysts estimate MBRX will report EPS of $-6.91 for the period ending 2026-12-31, with revenue estimated at $71M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.